Search results for "Risk factor."

showing 10 items of 4316 documents

Short Sleep Duration Is Related to Emerging Cardiovascular Risk Factors in Obese Children

2015

Objective: The aim of the present study was to evaluate the influence of sleep duration on cardiovascular risk factors in obese children. Methods: Cross-sectional analysis of 90 obese children ages 7 to 16 years. Anthropometric and clinical evaluation with specification of dietary and lifestyle habits was carried out during an office visit. Sleep duration was evaluated by the BEARS (B = bedtime issues, E = excessive daytime sleepiness, A = night awakening, R = regularity and duration of sleep, S = snoring) questionnaire on children's sleep characteristics. Sleep time adequacy by age was assessed according to the criteria of the National Sleep Foundation. Biochemical blood variables indicati…

Blood GlucoseMaleSleep Wake Disorderscardiovascular riskPediatric ObesityPediatricsmedicine.medical_specialtyobesityAdolescentCross-sectional studyThyrotropinBlood PressureBody Mass IndexAdipokinesRisk FactorsSurveys and QuestionnairesmedicineHumansInsulinDuration (project management)ChildHomocysteineMetabolic Syndromebusiness.industryGastroenterologyhomocysteineAnthropometrymedicine.diseaseretinol-binding proteinObesitySleep in non-human animalsC-Reactive ProteinCross-Sectional StudiesBlood pressureEl NiñoCardiovascular DiseasesObesity AbdominalPediatrics Perinatology and Child Healthsleep durationFemaleSleepbusinessRetinol-Binding Proteins PlasmaBody mass index
researchProduct

Association between WHO cut-offs for childhood overweight and obesity and cardiometabolic risk

2012

AbstractObjectiveTo examine the association between cardiovascular risk and childhood overweight and obesity using the BMI cut-offs recommended by the WHO.DesignChildren were classified as normal weight, overweight and obese according to the WHO BMI-for-age reference. Blood pressure, lipids, glucose, insulin, homeostasis model assessment–insulin resistance (HOMA-IR) and uric acid levels were compared across BMI groups. ANOVA and tests of linearity were used to assess overall mean differences across groups. Crude and adjusted odds ratios were calculated for adverse plasma levels of biochemical variables.SettingPaediatric care centres.SubjectsChildren (n149) aged 8–18 years.ResultsAbout 37 %,…

Blood GlucoseMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentMedicine (miscellaneous)Blood PressureOverweightWorld Health OrganizationBody Mass Indexchemistry.chemical_compoundInsulin resistanceRisk FactorsInternal medicinemedicineCluster AnalysisHumansInsulinObesityProspective StudiesChildNutrition and Dieteticsbusiness.industryInsulinMonitoring and SurveillanceCholesterol HDLPublic Health Environmental and Occupational Healthnutritional and metabolic diseasesCholesterol LDLOdds ratioOverweightmedicine.diseaseObesityUric AcidLogistic ModelsEndocrinologyBlood pressurechemistryCardiovascular DiseasesSpainHypertensionMultivariate AnalysisUric acidFemaleInsulin Resistancemedicine.symptombusinessBody mass indexFollow-Up Studies
researchProduct

Association between periodontal disease and non-fatal ischemic stroke: a case-control study

2014

This study aimed to investigate the association between clinical and radiological markers of periodontal disease and ischemic stroke and to assess the potential influence of inflammatory response on the observed associations.A prospective case-control study including a series of 48 cases with a minor ischemic stroke and 47 controls was conducted at the University Hospital of Dijon. Vascular risk factors, clinical dental examination (plaque index, gingival index, percentage of pockets5 mm, percentage of bleeding on probing (BOP) sites), dental panoramic (bone loss) and biological parameters (CRP, total cholesterol, HDL, LDL, fasting glucose) were collected. Conditional regression analyses we…

Blood GlucoseMalemedicine.medical_specialtyBleeding on probingAlveolar Bone LossBrain Ischemiachemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansPeriodontal PocketProspective StudiesRisk factorProspective cohort studyGeneral DentistryStrokePeriodontal DiseasesAgedPeriodontitisDMF Indexbusiness.industryCholesterolCholesterol HDLDental Plaque IndexCase-control studyCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseDental Plaque IndexSurgeryStrokeC-Reactive ProteinCholesterolchemistryCase-Control StudiesHypertensionFemalePeriodontal Indexmedicine.symptombusinessBiomarkersActa Odontologica Scandinavica
researchProduct

Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome

2009

Summary Objective  Small, dense low-density lipoproteins (LDL) are a feature of the metabolic syndrome (MS) but their predictive role still remains to be established. We performed a 2-year follow-up study in 124 subjects with MS (63 ± 6 years), as defined by the American Heart Association/National Heart, Lung and Blood Institute guidelines, to assess clinical and biochemical predictors of cerebro- and cardio-vascular events. Methods and results  Beyond traditional cardiovascular risk factors, we measured LDL size and subclasses by gradient gel electrophoresis. Clinical events were registered in the 25% of subjects. At univariate analysis subjects with events had increased prevalence of elev…

Blood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and Diabetology610 Medicine & healthCerebroCoronary artery diseaseEndocrinologyPredictive Value of TestsRisk FactorsInternal medicinemedicineHumansFamily historyLow-density lipoproteins (LDL metabolic syndromeAgedMetabolic SyndromeUnivariate analysisbusiness.industryMiddle Agedmedicine.disease1310 EndocrinologyLipoproteins LDL2712 Endocrinology Diabetes and MetabolismEndocrinologymedicine.anatomical_structureSmall dense low-density lipoproteins cardio events cerebro-vascular events the metabolic syndromeCardiovascular DiseasesPredictive value of testsCirculatory systemFemaleMetabolic syndromebusinessBlood vesselFollow-Up Studies
researchProduct

Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.

2021

Digital

Blood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismRecombinant Fusion ProteinsGlucagon-Like Peptides030209 endocrinology & metabolismType 2 diabetesPlacebolaw.invention03 medical and health sciences0302 clinical medicineEndocrinologyRandomized controlled trialDouble-Blind MethodErectile DysfunctionlawInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic Agents030212 general & internal medicineRisk factorAgedbusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseasePrognosisImmunoglobulin Fc FragmentsErectile dysfunctionDiabetes Mellitus Type 2Cardiovascular DiseasesDulaglutideFemalebusinessBiomarkersmedicine.drugFollow-Up StudiesThe lancet. Diabetesendocrinology
researchProduct

Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction.

2005

The impact of metabolic syndrome after acute myocardial infarction (AMI) has not yet been studied. In a population-based sample of patients with AMI, we sought to determine the prevalence of metabolic syndrome in patients with AMI, its impact on hospital outcomes, and to assess the relative influence of each of the components of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III definition of metabolic syndrome on the risk of death and heart failure.A total of 633 unselected, consecutive patients hospitalized with AMI were categorized according to the NCEP ATP III metabolic syndrome criteria (presence of/=3 of the following: hyperglycemia; triglyceride level/=…

Blood GlucoseMalemedicine.medical_specialtyHeart diseasePopulationMyocardial InfarctionPredictive Value of TestsRisk FactorsInternal medicineInternal MedicinemedicineOdds RatioPrevalenceHumanscardiovascular diseasesMyocardial infarctionHospital MortalityIntensive care medicineeducationNational Cholesterol Education Programhealth care economics and organizationsAgedRetrospective StudiesMetabolic Syndromeeducation.field_of_studybusiness.industryRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseLipidsCreatinineMyocardial infarction complicationsFemaleFranceMetabolic syndromebusinessBiomarkersArchives of internal medicine
researchProduct

Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One…

2018

OBJECTIVE The long-term impact of intentional weight loss on cardiovascular events remains unknown. We describe 12-month changes in body weight and cardiovascular risk factors in PREvención con DIeta MEDiterránea (PREDIMED)-Plus, a trial designed to evaluate the long-term effectiveness of an intensive weight loss lifestyle intervention on primary cardiovascular prevention. RESEARCH DESIGN AND METHODS Overweight/obese adults with metabolic syndrome aged 55–75 years (n = 626) were randomized to an intensive weight loss lifestyle intervention based on an energy-restricted Mediterranean diet, physical activity promotion, and behavioral support (IG) or a control group (CG). The primary and seco…

Blood GlucoseMalemedicine.medical_specialtyMediterranean dietEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismOverweightDiet Mediterraneanlaw.inventionPrediabetic State03 medical and health sciences0302 clinical medicineRandomized controlled triallawWeight lossBehavior TherapyRisk FactorsDiabetes mellitusInternal medicineWeight LossInternal MedicineMedicineHumans030212 general & internal medicineObesityExercise physiologyExerciseLife StyleAgedCaloric RestrictionAdvanced and Specialized NursingMetabolic Syndromebusiness.industryLeptinMiddle AgedOverweightmedicine.diseaseExercise TherapyCardiovascular DiseasesFemalemedicine.symptomMetabolic syndromebusinessFollow-Up Studies
researchProduct

Association between chronic dental infection and acute myocardial infarction.

2008

Introduction: In patients with cardiovascular diseases several risk factors such as high blood pressure, diabetes, smoking and drinking habits, genetic disposition, and chronic inflammation must be considered. The aim of this study was to investigate whether there is a correlation between dental origin infections and the presence of an acutemyocardialinfarction(AMI).Methods:Atotalof125 patients who had experienced a myocardial infarction and 125healthyindividualswereincludedinthisstudy.Theoral examination was carried out following the consent of the ethics committee and the National Board for Radiation Protection and included the number of teeth, endodontically treated teeth, periodontal sc…

Blood GlucoseMalemedicine.medical_specialtyMyocardial InfarctionInfarctionDentistryDiabetes ComplicationsLeukocyte CountTooth LossSex FactorsRisk FactorsInternal medicineDiabetes mellitusPeriodontal Attachment LossmedicineTooth lossHumansPeriodontal PocketMyocardial infarctionObesityGeneral DentistryPeriodontal DiseasesAgedAged 80 and overTooth Nonvitalbiologybusiness.industryPeriapical DiseasesC-reactive proteinSmokingCase-control studyAge FactorsDental Pulp DiseasesMiddle Agedmedicine.diseaseRadiographyC-Reactive ProteinClinical attachment lossTooth DiseasesCase-Control StudiesChronic Diseasebiology.proteinMyocardial infarction complicationsFemalemedicine.symptomPeriodontal IndexbusinessGingival HemorrhageJournal of endodontics
researchProduct

Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response

2000

Objectives: The aim of the present study was to evaluate the effects of pravastatin treatment on lipid, inflammation, and coagulation parameters in patients suffering from myocardial infarction with or without carotid atherosclerotic lesions (groups 1 and 2, respectively). Methods: In the first phase of the study, a cross-sectional comparison of lipid, inflammation, and coagulation parameters was performed between the patients and the control group (group 3). Highly significant differences in these parameters were observed, especially in group 1. In the second phase of the study, we assessed the effects of a persistent reduction in cholesterol synthesis induced by increasing doses of pravas…

Blood GlucoseMalemedicine.medical_specialtyMyocardial InfarctionInflammationCoronary Artery DiseaseFibrinogenchemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansPharmacology (medical)PravastatinInflammationPharmacologyDose-Response Relationship DrugFactor VIIbusiness.industryCholesterolpravastatin inflammatory responseGeneral MedicineMiddle AgedBlood Coagulation FactorsCholesterolCross-Sectional StudiesEndocrinologyCoagulationchemistryCase-Control StudiesHemostasisFemalelipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsmedicine.symptombusinessPravastatinmedicine.drugLipoproteinEuropean Journal of Clinical Pharmacology
researchProduct

Insulin resistance and atrial fibrillation (from the Framingham Heart Study)

2011

Diabetes mellitus and obesity are increasing in prevalence and are associated with an elevated risk of atrial fibrillation (AF). Given the aging of the United States population, AF is projected to concomitantly increase in prevalence in the upcoming decades. Both diabetes and obesity are associated with insulin resistance. Whether insulin resistance is an intermediate step for the development of AF is uncertain. We hypothesized that insulin resistance is associated with an increased risk of incident AF. We examined the association of insulin resistance with incident AF using multivariate Cox proportional hazards regression analysis adjusting for the established AF risk factors (i.e., age, g…

Blood GlucoseMalemedicine.medical_specialtyPopulationArticleDISEASEBody Mass IndexFramingham Heart StudyInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusAtrial FibrillationConfidence IntervalsMedicineHumansInsulinCOHORTeducationAgedProportional Hazards ModelsRetrospective StudiesMETABOLIC SYNDROMERISKeducation.field_of_studyFramingham Risk Scorebusiness.industryIncidenceHazard ratioDIABETES-MELLITUSMENASSOCIATIONmedicine.diseaseMassachusettsATHEROSCLEROSISHomeostatic model assessmentCardiologyFemaleMetabolic syndromeInsulin ResistanceCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesAmerican Journal of Cardiology
researchProduct